(Nasdaq: CODX) ("Co-Dx" or the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today highlighted capabilities of its ...
A study of 511 participants in Nigeria found that a PfHRP2-based rapid diagnostic test detected most malaria infections ...
The US Food and Drug Administration has cleared a new multiplex gastrointestinal PCR assay designed to streamline the detection of common diarrhea-causing pathogens from a single patient sample. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results